Cognition Therapeutics, Inc.
CGTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,930 | -$6,734 | -$8,480 | -$7,842 |
| Dep. & Amort. | $61 | $61 | $45 | $71 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $621 | $586 | $534 |
| Change in WC | -$1,304 | $429 | -$2,028 | -$1,145 |
| Other Non-Cash | $522 | $0 | $0 | $0 |
| Operating Cash Flow | -$5,651 | -$5,623 | -$9,877 | -$8,382 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$41 | -$120 | -$118 | -$195 |
| Stock Issued | $33,994 | $877 | $1,460 | $11,576 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$36 | -$5 | -$46 | $0 |
| Financing Cash Flow | $33,917 | $752 | $1,296 | $11,381 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $28,266 | -$4,871 | -$8,581 | $2,998 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $11,557 | $16,428 | $25,009 | $22,011 |
| End Cash | $39,823 | $11,557 | $16,428 | $25,009 |
| Free Cash Flow | -$5,651 | -$5,623 | -$9,877 | -$8,383 |